PRINCETON, N.J. — Derma Sciences, Inc. (Nasdaq: DSCI), a
medical device and pharmaceutical company focused on advanced wound care,
announces that its chief executive officer, Edward J. Quilty, highlighted the
rapid growth of MEDIHONY® Dressings with medical grade Manuka (Leptospermum)
Honey, and the rewarding relationship between Derma Sciences and Comvita
Limited in a presentation at Comvita’s annual shareholders’ meeting in New
Zealand yesterday. MEDIHONEY is the leading brand of medical grade honey products
and is one of the fastest-growing moist wound healing wound dressings in the
field of advanced wound care, with a sales growth rate exceeding 30% annually…
No comments:
Post a Comment